Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release
Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release
复制标题
DOI:
10.1023/a:1022576405534
复制
发表时间:
1999-11-01
影响因子:
4.4
通讯作者:
Chavez, P
中科院分区:
文献类型:
--
作者:
Ortiz, JG;Nieves-Natal, J;Chavez, P
Extracts of Valeriana officinalis have been used in folkloric medicine for its sedative, hypnotic, tranquilizer and anticonvulsant effects, and may interact with gamma-aminobutyric acid (GABA) and/or benzodiazepine sites. At low concentrations, valerian extracts enhance [H-3]flunitrazepam binding (EC50 4.13 x 10(-10) mg/ml). However, this increased [H-3]flunitrazepam binding is replaced by an inhibition at higher concentrations (IC50 Of 4.82 x 10(-1) mg/ml). These results are consistent with the presence of at least two different biological activities interacting with [H-3]flunitrazepam binding sites. Valerian extracts also potentiate K+ or veratridine-stimulated release of radioactivity from hippocampal slices preloaded with [H-3]GABA. Finally, inhibition of synaptosomal [H-3]GABA uptake by valerian extracts also displays a biphasic interaction with guvacine. The results confirm that valerian extracts have effects on GABAA receptors, but can also interact at other presynaptic components of GABAergic neurons.